| Phase I Trial of S-1153 in Patients With HIV Infection (NCT00002214) | Lexigen Pharmaceuticals | |
| A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children (NCT00000952) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women (NCT01490671) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial (NCT00002032) | Pharmacia | |
| A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients (NCT00000973) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir (NCT00001095) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults (NCT01970449) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients (NCT00000650) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of LXR015-1 in HIV-Infected Patients (NCT00002365) | LXR Biotechnology | |
| A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma (NCT00002314) | Hoffmann-La Roche | |
| A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive (NCT00002215) | Triangle Pharmaceuticals | |
| A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma (NCT00000996) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS (NCT00002142) | Gilead Sciences | |
| Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People (NCT00028366) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites (NCT00000826) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-Dideoxyinosine or 2',3'-Dideoxycytidine in Patients With Human Immunodeficiency Virus Disease (NCT00002001) | Glaxo Wellcome | |
| A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus (NCT00000993) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems (NCT00002304) | Pfizer | |
| A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex (NCT00002005) | Genentech, Inc. | |
| Safety and Effectiveness of Adding Saquinavir (FORTOVASE) in Soft Gel Capsule Form to an Anti-HIV Drug Combination in HIV-Infected Patients (NCT00002229) | Hoffmann-La Roche | |
| The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine (NCT00002381) | Boehringer Ingelheim | |
| A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex (NCT00001004) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection (NCT00000652) | National Cancer Institute (NCI) | |
| The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients (NCT00000860) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients (NCT00002223) | Abbott | |
| A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma (NCT00000694) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time (NCT00001002) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility (NCT00002006) | Sandoz | |
| Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders (NCT00002153) | DEKK-TEC, Inc. | |
| A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections (NCT00002277) | Pfizer | |
| Vitamin B Therapy for Hyperlactatemia (NCT00031057) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia (NCT00001104) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Metabolic Effects of Protease Inhibitors in HIV Infected Children (NCT00004739) | National Center for Research Resources (NCRR) | |
| A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine (NCT00000628) | Merck Sharp & Dohme LLC | |
| A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP (NCT00000998) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals (NCT00002087) | Pharmacia and Upjohn | |
| A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV (NCT00001049) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected Patients (NCT00002084) | Glaxo Wellcome | |
| The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year (NCT00000848) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection (NCT00001117) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months (NCT00006279) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Tolerance of Zidovudine With Probenecid and the Effect of Probenecid on Zidovudine Pharmacokinetics Over Four Weeks (NCT00000670) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids (NCT00006412) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328 (NCT00000923) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease (NCT00002166) | Boehringer Ingelheim | |
| A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160 (NCT00000745) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Viracept in HIV-Positive Women (NCT00002171) | Agouron Pharmaceuticals | |
| A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults (NCT00001096) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies (NCT00000888) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy (NCT00085761) | NeurogesX | |
| A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection (NCT00001000) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Stem Cells and Filgrastim (NCT00001071) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection (NCT00000647) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC (NCT00000718) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection (NCT00000669) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine (NCT00002312) | Pharmacia and Upjohn | |
| Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic Individuals (NCT00000664) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS (NCT00000987) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children. (NCT00000833) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients (NCT00002350) | Apollon | |
| Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen (NCT00000903) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. (NCT00002093) | Nexstar Pharmaceuticals | |
| Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients (NCT00001048) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell (NCT00002323) | Boehringer Ingelheim | |
| Increasing HAART-Induced Immune Restoration With Cyclosporine (NCT00031070) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study. (NCT00002253) | Sandoz | |
| A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment (NCT00000671) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma (NCT00000687) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome (NCT00002157) | Celgene Corporation | |
| A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient (NCT00002184) | Gilead Sciences | |
| Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma (NCT00002226) | SUGEN | |
| Safety and Effectiveness of Adding PMPA Prodrug to an Anti-HIV Drug Combination to Treat HIV-Infected Patients (NCT00002415) | Gilead Sciences | |
| Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults (NCT00119873) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection (NCT00000995) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection (NCT00002086) | Glaxo Wellcome | |
| Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease (NCT00001045) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC (NCT00000711) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Treatment of Tuberculosis in HIV-Infected Patients (NCT00001033) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications (NCT00002417) | Glaxo Wellcome | |
| Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults (NCT00115960) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine (NCT00000770) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV (NCT00021762) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen (NCT00018083) | National Center for Research Resources (NCRR) | |
| The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV (NCT00001105) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluation of the Therapeutic Benefit of r-metHuIFN- Gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study (NCT00002037) | Amgen | |
| A Study of Isoprinosine in Patients With Severe AIDS (NCT00002295) | Newport Pharmaceuticals International | |
| Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy (NCT00000831) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCP (NCT00002053) | Fisons | |
| Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine (NCT00000734) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past (NCT00001029) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia (NCT00002067) | Bristol-Myers Squibb | |
| A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir (NCT00002452) | Merck Sharp & Dohme LLC | |
| Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure (NCT00002047) | Glaxo Wellcome | |
| Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune) (NCT00005001) | Agouron Pharmaceuticals | |
| A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients (NCT00000699) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Patients With AIDS Syndrome (NCT00001120) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Acupressure to Treat Nausea and Vomiting in HIV/AIDS Patients (NCT00017823) | National Institute of Nursing Research (NINR) | |
| A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC) (NCT00002254) | Lederle Laboratories | |
| The Safety and Effectiveness of Injections of Human Recombinant Interferon-gamma in Patients With AIDS Who Have Taken Zidovudine (NCT00001112) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors (NCT00002235) | Merck Sharp & Dohme LLC | |